Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Regenerative Medicine market was valued at 9648 Million US$ in 2018 and is projected to reach 28662 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.58% during the forecast period.
This report presents the market size and development trends by detailing the Regenerative Medicine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Regenerative Medicine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Regenerative Medicine industry and will help you to build a panoramic view of the industrial development.
Regenerative Medicine Market, By Type:
Cell Therapy
Gene Therapy
Tissue Engineering
Small Molecule & Biologic
Regenerative Medicine Market, By Application:
Cardiovascular
Oncology
Dermatology
Musculoskeletal
Wound Healing
Ophthalmology
Neurology
Others
Some of the leading players are as follows:
Integra Lifesciences Holdings Corporation
Stryker Corporation
CryoLife, Inc
Zimmer Biomet Holdings, Inc
Isto Biologics
Organogenesis, Inc
Acelity Holdings, Inc
Athersys, Inc
U.S. Stem Cell, Inc
Medtronic Plc.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Regenerative Medicine Market: Technology Type Analysis
-
4.1 Regenerative Medicine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Regenerative Medicine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Cell Therapy
4.3.2 Gene Therapy
4.3.3 Tissue Engineering
4.3.4 Small Molecule & Biologic
5 Regenerative Medicine Market: Product Analysis
-
5.1 Regenerative Medicine Product Market Share Analysis, 2018 & 2026
-
5.2 Regenerative Medicine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Regenerative Medicine Market: Application Analysis
-
6.1 Regenerative Medicine Application Market Share Analysis, 2018 & 2026
-
6.2 Regenerative Medicine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Cardiovascular
6.3.2 Oncology
6.3.3 Dermatology
6.3.4 Musculoskeletal
6.3.5 Wound Healing
6.3.6 Ophthalmology
6.3.7 Neurology
6.3.8 Others
7 Regenerative Medicine Market: Regional Analysis
-
7.1 Regenerative Medicine Regional Market Share Analysis, 2018 & 2026
-
7.2 Regenerative Medicine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Integra Lifesciences Holdings Corporation
9.1.1 Integra Lifesciences Holdings Corporation Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Stryker Corporation
9.2.1 Stryker Corporation Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 CryoLife, Inc
9.3.1 CryoLife, Inc Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Zimmer Biomet Holdings, Inc
9.4.1 Zimmer Biomet Holdings, Inc Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Isto Biologics
9.5.1 Isto Biologics Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Organogenesis, Inc
9.6.1 Organogenesis, Inc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Acelity Holdings, Inc
9.7.1 Acelity Holdings, Inc Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Athersys, Inc
9.8.1 Athersys, Inc Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 U.S. Stem Cell, Inc
9.9.1 U.S. Stem Cell, Inc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Medtronic Plc.
9.10.1 Medtronic Plc. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 97 Figures and 162 Tables)
Figure Cell Therapy Regenerative Medicine market, 2015 - 2026 (USD Million)
Figure Gene Therapy Regenerative Medicine market, 2015 - 2026 (USD Million)
Figure Tissue Engineering Regenerative Medicine market, 2015 - 2026 (USD Million)
Figure Small Molecule & Biologic Regenerative Medicine market, 2015 - 2026 (USD Million)
Figure Cardiovascular market, 2015 - 2026 (USD Million)
Figure Oncology market, 2015 - 2026 (USD Million)
Figure Dermatology market, 2015 - 2026 (USD Million)
Figure Musculoskeletal market, 2015 - 2026 (USD Million)
Figure Wound Healing market, 2015 - 2026 (USD Million)
Figure Ophthalmology market, 2015 - 2026 (USD Million)
Figure Neurology market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Regenerative Medicine market, by country, 2015 - 2026 (USD Million)
-
Table North America Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table North America Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table North America Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Regenerative Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table France Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table France Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Regenerative Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table China Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table China Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table India Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table India Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Regenerative Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Regenerative Medicine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Regenerative Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Regenerative Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Regenerative Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Integra Lifesciences Holdings Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Stryker Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CryoLife, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zimmer Biomet Holdings, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Isto Biologics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Organogenesis, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Acelity Holdings, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Athersys, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table U.S. Stem Cell, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medtronic Plc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
